Implementation of Individualized Medicine: Education, Prediction and Treatment

Not Applicable

Completed

• Conditions: ewly diagnosed hypertension encoded I10 (hypertension i.e. essential or primary arterial hypertension i.e. high blood pressure) or I11.9 (hypertensive heart disease with no (congestive) heart failure).; Circulatory System; Essential (primary) hypertension

• Registration Number: ISRCTN90092922
• Lead Sponsor: Archimedes Foundation (Estonia)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2014-04-15
• Study Completion: 2015-08-31
• Last Update Posted: 24 August 2020

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 300

Inclusion Criteria

Male, 18 to 65 years of age, who is subject to one of the followings:
1. Newly diagnosed hypertension* encoded** I10 [hypertension i.e. essential or primary arterial hypertension i.e. high blood pressure) or I11.9 (hypertensive heart disease with no (congestive) heart failure] or previously diagnosed hypertension encoded I10 or I11.9, with no medication treatment receive or previously diagnosed hypertension encoded I10 or I11.9 with assigned medication treatment that has been discontinued at least two months ago
* mean arterial blood pressure of three measurements: systolic over 140; and/or diastolic over 90 mmHg
** here and hereinafter the diagnosis codes are presented according to the 10th revision of the International Classification of Diseases
The patient shall (re)start the medication treatment of hypertension according to the physician?s assessment
2. ECG findings: sinus rhythm, without signs of having suffered from myocardial infraction and/or of acute ischemia
3. Gives an informed consent to participate in the study
4. The subject is prepared to find out his genetic risks

Exclusion Criteria

Physical or psychological comorbidities/conditions or their treatment which, according to the attending physician's assessment, may prevent or significantly affect:
1. Giving the informed consent
2. Participating in the study
3. The mean arterial blood pressure of three measurements during Visit 1: systolic over 180; and/or diastolic over 110 mmHg

Study & Design

• Study Type: Interventional
• Study Design: Not specified